✨ Unlock Unlimited Data Exports & Disclosures Access with Tracenable Pro. Learn More →

Catalent Inc

Common Name
Catalent
Country
United States
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
17,000
Ticker
CTLT
Exchange
NEW YORK STOCK EXCHANGE, INC.
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates in ...

Disclosures of Catalent

Explore Catalent's complete collection of publicly available corporate disclosures, including annual reports, sustainability reports, financial statements, ESG data spreadsheets, and related web publications. Each document is sourced directly from Catalent's official channels and fully traceable to its official company sources.

The table below lists all of Catalent's' corporate disclosure by name and reporting period, ensuring full transparency and easy access.

If you want to search across Catalent's' disclosures for specific data or insights, use our Disclosure Search.

NameReporting Period
10-K
2024
10-K
2024
Financial & Extra-Financial Disclosure
2024
Financial & Extra-Financial Disclosure
2023
ISAE Assurance Statement
2023
ISAE Assurance Statement
2023
Corporate Responsibility Report (CRR)
2023
10-K
2023
Webpage captured from company’s website
2023
10-K
2022
Verification report
2022
Corporate Responsibility Report (CRR)
2022
Verification report
2022
10-K
2021
Corporate Responsibility Report (CRR)
2021
10-K
2020
CSR Report
2020
10-K
2019
CSR Report
2019
10-K
2018
10-K
2017
10-K
2016
10-K
2015
10-K
2014
Real-Time Disclosures Datafeed

Get Notified Within Seconds of New Corporate Disclosures

Tracenable is building a high-speed disclosure monitoring system that delivers instant alerts when companies publish new reports or data. Could a real-time datafeed (via SFTP, RSS or API) enhance your investment or analytical workflows?